Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
QNTM
Stock Latest News
Company Announcements
Quantum BioPharma Cleared to Proceed With $700 Million Market Manipulation Lawsuit After Motion to Dismiss Largely Denied
8d ago
6K
QNTM
Premium
Company Announcements
Quantum BioPharma Files FDA IND for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
9d ago
6K
QNTM
Premium
The Fly
Quantum BioPharma submits Lucid-21-302 new drug application to the FDA
9d ago
QNTM
Premium
Company Announcements
Quantum BioPharma Taps Allucent for Phase 2 Trial of Novel MS Drug Lucid-MS
11d ago
6K
QNTM
Premium
The Fly
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
11d ago
QNTM
Premium
The Fly
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
11d ago
QNTM
Premium
Company Announcements
Quantum BioPharma Posts Strong 2025 Results, Extends Cash Runway and Advances MS and Alcohol Health Programs
14d ago
6K
QNTM
Premium
Company Announcements
Quantum BioPharma Taps MS Expert to Lead Phase 2 Trial of Lucid-MS
15d ago
6K
QNTM
Premium
Pre-Earnings
Is QNTM a Buy, Before Earnings?
17d ago
QNTM
Premium
Company Announcements
Quantum BioPharma Wins Peer-Reviewed Validation for Unbuzzd Alcohol-Relief Supplement
18d ago
6K
QNTM
Premium
Company Announcements
Quantum BioPharma Raises C$3.75 Million and Converts Debt in Capital Restructuring Push
20d ago
QNTM
Premium
Company Announcements
Quantum BioPharma Eases Debenture Terms After Share Price Drop
29d ago
QNTM
Premium
Company Announcements
Quantum BioPharma Plans Convertible Debenture Financing and Debt-for-Equity Swap Ahead of 2025 Results
1M ago
QNTM
Premium
Company Announcements
Quantum BioPharma Completes 180-Day Toxicity Dosing for Lead MS Drug Lucid-MS
4M ago
6K
QNTM
Premium
The Fly
Quantum Group completes dosing in 180-day study of Lucid-MS
4M ago
QNTM
Premium
Company Announcements
Quantum BioPharma Launches US$17.2 Million ATM Equity Program on Nasdaq
4M ago
6K
QNTM
Premium
Company Announcements
Quantum BioPharma Moves to Lead Class Action Alleging Bank Manipulation of Its Shares
4M ago
6K
QNTM
Premium
The Fly
Quantum shareholder files class action lawsuit against the company
4M ago
QNTM
Premium
Company Announcements
Quantum BioPharma Moves to Lead Class Action Over Alleged Stock Manipulation by Canadian Banks
4M ago
QNTM
Premium
Company Announcements
Quantum BioPharma Closes Private Placement, Enhances Governance
4M ago
QNTM
Premium
Company Announcements
Quantum BioPharma Ends Market Offering Agreement
4M ago
6K
QNTM
Premium
Company Announcements
Quantum BioPharma’s Lawsuit Highlighted in CTV’s W5 Series
4M ago
6K
QNTM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.